6.27
price down icon1.72%   -0.11
after-market 시간 외 거래: 6.38 0.11 +1.75%
loading
전일 마감가:
$6.38
열려 있는:
$6.38
하루 거래량:
214.65K
Relative Volume:
3.04
시가총액:
$104.87M
수익:
-
순이익/손실:
$-14.88M
주가수익비율:
-6.398
EPS:
-0.98
순현금흐름:
$-10.29M
1주 성능:
-4.42%
1개월 성능:
-2.49%
6개월 성능:
-3.83%
1년 성능:
+3.47%
1일 변동 폭
Value
$5.96
$6.605
1주일 범위
Value
$5.96
$6.80
52주 변동 폭
Value
$4.65
$10.24

Coya Therapeutics Inc Stock (COYA) Company Profile

Name
명칭
Coya Therapeutics Inc
Name
전화
650.739.3939
Name
주소
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Name
직원
8
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
COYA's Discussions on Twitter

COYA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
COYA
Coya Therapeutics Inc
6.27 106.71M 0 -14.88M -10.29M -0.98
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-09 개시 Lake Street Buy
2024-12-04 개시 D. Boral Capital Buy

Coya Therapeutics Inc 주식(COYA)의 최신 뉴스

pulisher
02:30 AM

Is a relief rally coming for Coya Therapeutics Inc. holdersEarnings Risk Summary & Community Consensus Picks - Newser

02:30 AM
pulisher
05:17 AM

Aug Retail: Can Coya Therapeutics Inc. expand into new marketsJuly 2025 Volume & Technical Pattern Alert System - خودرو بانک

05:17 AM
pulisher
Sep 05, 2025

Multi factor analysis applied to Coya Therapeutics Inc.Market Risk Analysis & Weekly Watchlist of Top Performers - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

How to forecast Coya Therapeutics Inc. trends using time seriesMarket Movers & Low Drawdown Momentum Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

does coya therapeutics inc. show high probability of reboundMarket Trend Report & Weekly Market Pulse Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Quarterly Recap: Is now the right time to enter Coya Therapeutics Inc.Weekly Loss Report & AI Forecast Swing Trade Picks - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

How high can Coya Therapeutics Inc. stock go2025 Geopolitical Influence & Weekly Breakout Watchlists - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Does Coya Therapeutics Inc. show high probability of reboundQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Earnings visualization tools for Coya Therapeutics Inc.Breakout Watch & Technical Entry and Exit Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Can Coya Therapeutics Inc. expand into new marketsQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

What’s the recovery path for long term holders of Coya Therapeutics Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Visual trend scoring systems applied to Coya Therapeutics Inc.Short Setup & Daily Volume Surge Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Applying Elliott Wave Theory to Coya Therapeutics Inc.2025 Valuation Update & Fast Moving Stock Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Does Coya Therapeutics Inc. stock have upside surprise potential2025 Technical Patterns & Weekly Breakout Stock Alerts - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Will Coya Therapeutics Inc. benefit from seasonalityJuly 2025 Earnings & Safe Investment Capital Preservation Plans - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Coya Therapeutics to Participate at Upcoming September Investor Conferences - Eastern Progress

Sep 04, 2025
pulisher
Sep 04, 2025

Coya Therapeutics shares rise 1.20% premarket after FDA acceptance of COYA 302 IND for ALS trial. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Coya Therapeutics' ALS Trial Affiliated with NEALS, Preparing for Q4 2025 Initiation - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Coya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial - PR Newswire

Sep 04, 2025
pulisher
Sep 04, 2025

Coya Therapeutics Inc. recovery potential after sell offPrice Action & High Accuracy Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Coya Therapeutics Highlights Q2 2025 Financial Results - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

What Fibonacci levels say about Coya Therapeutics Inc. reboundCPI Data & Accurate Entry and Exit Point Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is Coya Therapeutics Inc. in a long term uptrend2025 Sector Review & Real-Time Stock Price Movement Reports - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Can Coya Therapeutics Inc. hit a new high this monthMarket Performance Report & AI Powered Buy and Sell Recommendations - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is Coya Therapeutics Inc. trending in predictive chart models2025 Technical Overview & Stepwise Trade Execution Plans - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is Coya Therapeutics Inc. stock ready for a breakoutQuarterly Profit Report & Free Technical Pattern Based Buy Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Coya Therapeutics Inc. lead its sector in growthWeekly Market Report & Consistent Profit Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Coya Therapeutics shares rise 1.61% intraday after FDA IND clearance for ALS trial and strategic partnerships. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

PRISM MarketView Features Exclusive Q&A with Coya Therapeutics CEO Arun Swaminathan on Targeting Neurodegenerative Diseases Through Treg Therapies - SINA HONG KONG LIMITED

Sep 03, 2025
pulisher
Sep 03, 2025

Coya Therapeutics CEO Arun Swaminathan Discusses FDA Clearance, Partnerships, and 2025 Milestones for ALS and Neurodegeneration Programs - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

PRISM MarketView Features Exclusive Q&A with Coya - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Will Coya Therapeutics Inc. stock recover after recent dropPortfolio Growth Summary & Real-Time Chart Pattern Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Coya Therapeutics Receives $4.2M Milestone Payment - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

How much upside does Coya Therapeutics Inc. have2025 Technical Patterns & Low Risk High Reward Ideas - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Coya gets FDA clearance to start Phase 2 trial of ALS treatment - ALS News Today

Sep 02, 2025
pulisher
Sep 02, 2025

Should I buy Coya Therapeutics Inc. stock nowJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Has Coya Therapeutics Inc. found a price floorJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Coya Therapeutics Inc. stock momentum explained2025 Momentum Check & Free Community Supported Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using portfolio simulators with Coya Therapeutics Inc. includedPortfolio Update Report & Breakout Confirmation Trade Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Coya Therapeutics Inc. outperform under higher oil pricesQuarterly Investment Review & Stepwise Trade Signal Implementation - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Should I hold or sell Coya Therapeutics Inc. nowJuly 2025 Analyst Calls & Safe Entry Trade Signal Reports - خودرو بانک

Sep 01, 2025

Coya Therapeutics Inc (COYA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):